186 related articles for article (PubMed ID: 21850908)
1. Still golden? More companies eyeing healthcare, but newcomers need to deliver real value.
May D
Mod Healthc; 2011 Jun; 41(26):20. PubMed ID: 21850908
[No Abstract] [Full Text] [Related]
2. 2006 AHA environmental assessment.
O'Dell GJ
Trustee; 2006 Oct; 59(9):23-5, 27-30, 32-3. PubMed ID: 17058703
[No Abstract] [Full Text] [Related]
3. Dualistic healthcare markets: the impact of boutique offerings.
Stanfill PH
J Oncol Manag; 2000; 9(4):13-20. PubMed ID: 11186507
[TBL] [Abstract][Full Text] [Related]
4. Managing manpower and cutting costs in the health care industry.
Kocakülâh MC; Wiggins LM; Albin M
J Health Care Finance; 2009; 35(3):80-92. PubMed ID: 19891209
[TBL] [Abstract][Full Text] [Related]
5. Fewer alternatives? Ancillary businesses become less of a focus for some hospitals and health systems, but they still fill a niche, and many organizations see financial, operational advantages.
Evans M
Mod Healthc; 2011 Jun; 41(26):26, 28, 30. PubMed ID: 21853609
[No Abstract] [Full Text] [Related]
6. The value marketing chain in health care.
MacStravic S
Mark Health Serv; 1999; 19(1):14-9. PubMed ID: 10351394
[TBL] [Abstract][Full Text] [Related]
7. Assisted living. Moving into new markets.
Lawson K
Contemp Longterm Care; 1998 Aug; 21(8):54, 56, 58. PubMed ID: 10185272
[No Abstract] [Full Text] [Related]
8. Managed competition. Using market incentives to control costs, quality.
Durenberger D
Minn Med; 1994 Sep; 77(9):25-6. PubMed ID: 7968950
[No Abstract] [Full Text] [Related]
9. Rx for investors.
Stires D
Fortune; 2004 May; 149(9):158-60, 162, 164 passim. PubMed ID: 15124332
[No Abstract] [Full Text] [Related]
10. An empirical analysis of health care IPOs and SEOs.
Brau JC; Holloway JM
J Health Care Finance; 2009; 35(4):42-63. PubMed ID: 20515009
[TBL] [Abstract][Full Text] [Related]
11. Fiscal accountability comes to marketing. Create a system that controls costs and measures ROI.
McMurry P
Healthc Exec; 1988; 3(3):26-7. PubMed ID: 10302701
[No Abstract] [Full Text] [Related]
12. Seven guidelines for approaching the new growth mandate.
Goldman EF
Healthc Strateg; 1999 Mar; 3(3):1-6. PubMed ID: 10346555
[No Abstract] [Full Text] [Related]
13. Keys to a high-performance health system for the United States.
Schoenbaum SC
Healthc Financ Manage; 2006 Jul; 60(7):60-4, 66. PubMed ID: 16869325
[TBL] [Abstract][Full Text] [Related]
14. IPO resurgence. Healthcare services offerings show signs of life after two slow years.
Jaklevic MC
Mod Healthc; 2001 Feb; 31(9):40, 43. PubMed ID: 11246772
[No Abstract] [Full Text] [Related]
15. Environmental scan 2013.
Trustee; 2012 Sep; 65(8):12 p following 16. PubMed ID: 23057167
[No Abstract] [Full Text] [Related]
16. Lessons from the business side of healthcare.
Lanser EG
Healthc Exec; 2000; 15(5):14-9. PubMed ID: 11183943
[No Abstract] [Full Text] [Related]
17. Vulnerability of health to market forces.
Brezis M; Wiist WH
Med Care; 2011 Mar; 49(3):232-9. PubMed ID: 21301368
[TBL] [Abstract][Full Text] [Related]
18. U.S. health care: in need of an industrial revolution?
McDaniel D; D'Orazio D
Md Med; 2011; 12(2):8-11. PubMed ID: 21830642
[No Abstract] [Full Text] [Related]
19. The "commoditization" of medicine.
Joseph SR
J Cardiovasc Manag; 1998; 9(3):26-7. PubMed ID: 10181700
[No Abstract] [Full Text] [Related]
20. Vanguard IPO comes in low.
Galloro V
Mod Healthc; 2011 Jun; 41(26):14. PubMed ID: 21853606
[No Abstract] [Full Text] [Related]
[Next] [New Search]
